Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria

• Published in: PloS one Vol. 11; no. 8; p. e0160894
• Main Authors: Garsen, Marjolein, Rops, Angelique L, Li, Jinhua, van Beneden, Katrien, van den Branden, Christiane, Berden, Jo Hm, Rabelink, Ton J, van der Vlag, Johan
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 09-08-2016; Public Library of Science (PLoS)
• Subjects: Albumins - metabolism; Animals; Arginine - analogs & derivatives; Arginine - pharmacology; Biology; Biology and Life Sciences; Development and progression; Diabetes; Diabetes mellitus; Doxorubicin - pharmacology; Endothelial cells; Endothelium; Enzyme Induction - drug effects; Gene expression; Gene Expression Regulation, Enzymologic - drug effects; Genetic aspects; Glomerulonephritis; Glucuronidase - biosynthesis; Glucuronidase - genetics; Heparan sulfate; Kinases; Laboratories; Ligases; Medicine and Health Sciences; Mice; Mice, Inbred BALB C; Nephrology; Nephropathy; Nitric oxide; Nitric Oxide Synthase Type III - metabolism; Nitric-oxide synthase; Physiological aspects; Proteinuria; Proteinuria - chemically induced; Proteinuria - enzymology; Proteinuria - genetics; Proteinuria - prevention & control; Research and Analysis Methods; Rodents; Tumor necrosis factor-TNF; Netherlands; Belgium; United States > US
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0160894

Endothelial nitric oxide synthase (eNOS) deficiency exacerbates proteinuria and renal injury in several glomerular diseases, but the underlying mechanism is not fully understood. We recently showed that heparanase is essential for the development of experimental diabetic nephropathy and glomerulonephritis, and hypothesize that heparanase expression is regulated by eNOS. Here, we demonstrate that induction of adriamycin nephropathy (AN) in C57BL/6 eNOS-deficient mice leads to an increased glomerular heparanase expression accompanied with overt proteinuria, which was not observed in the AN-resistant wild type counterpart. In vitro, the eNOS inhibitor asymmetric dimethylarginine (ADMA) induced heparanase expression in cultured mouse glomerular endothelial cells. Moreover, ADMA enhanced transendothelial albumin passage in a heparanase-dependent manner. We conclude that eNOS prevents heparanase induction and the development of proteinuria.